- Company Overview for INPHARM HOLDCO LTD (14272464)
- Filing history for INPHARM HOLDCO LTD (14272464)
- People for INPHARM HOLDCO LTD (14272464)
- More for INPHARM HOLDCO LTD (14272464)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
27 Feb 2024 | GAZ2(A) | Final Gazette dissolved via voluntary strike-off | |
12 Dec 2023 | GAZ1(A) | First Gazette notice for voluntary strike-off | |
29 Nov 2023 | DS01 | Application to strike the company off the register | |
25 Sep 2023 | SH01 |
Statement of capital following an allotment of shares on 14 September 2023
|
|
21 Aug 2023 | CS01 | Confirmation statement made on 2 August 2023 with updates | |
02 Aug 2023 | AD01 | Registered office address changed from Suite 1, 7th Floor 50 Broadway London SW1H 0BL United Kingdom to Devonshire House 1 Mayfair Place C/O Letterone London W1J 8AJ on 2 August 2023 | |
02 Aug 2023 | TM02 | Termination of appointment of Vistra Cosec Limited as a secretary on 31 July 2023 | |
23 Feb 2023 | AD01 | Registered office address changed from Suite 1, 3rd Floor 11 - 12 st James's Square London SW1Y 4LB United Kingdom to Suite 1, 7th Floor 50 Broadway London SW1H 0BL on 23 February 2023 | |
22 Feb 2023 | PSC08 | Notification of a person with significant control statement | |
22 Feb 2023 | PSC07 | Cessation of Mubashir Mukadam as a person with significant control on 11 February 2023 | |
13 Feb 2023 | AP01 | Appointment of Philip Christoph Urs Buergin as a director on 10 February 2023 | |
13 Feb 2023 | TM01 | Termination of appointment of Barclay Jackson Morison as a director on 10 February 2023 | |
03 Aug 2022 | NEWINC |
Incorporation
Statement of capital on 2022-08-03
|